Nanosonics on track for US market
June 29, 2010
Nanosonics Limited (NAN) this morning said it has re-commenced production and shipment of its upgraded Trophon EPR devices, used for disinfecting ultrasound devices, following successful trials of the product. The company also said that its application for approval by the FDA was “firmly on track”.
Currently Nanosonics said it was finalising specifications and validation of a chemical indicator to meet US regulatory standards.
”Pending completion of this work and FDA approval, the Company remains on track for an initial product launch into the US market during 2011,” the company said.
Meanwhile in Australia, Nanosonics was upping production at its Alexandria, NSW premises and it currently held orders for over three months of production capacity.
At 1057 AEST, Nanosonics shares were trading up 1.5c to 54c.
Currently Nanosonics said it was finalising specifications and validation of a chemical indicator to meet US regulatory standards.
”Pending completion of this work and FDA approval, the Company remains on track for an initial product launch into the US market during 2011,” the company said.
Meanwhile in Australia, Nanosonics was upping production at its Alexandria, NSW premises and it currently held orders for over three months of production capacity.
At 1057 AEST, Nanosonics shares were trading up 1.5c to 54c.
Leave a Reply